Report ID: PMRREP2995
Number of Pages: 167
Format: PPT*, PDF, EXCEL
Industry: Healthcare
Published Date: June-2024
The market is estimated to reach a valuation of US$20.9 Bn by the year 2033, at a CAGR of 10.2%, during the forecast period of 2024 to 2033.
Key Highlights of the Market
|
Attributes |
Key Insights |
|
microfluidic devices market Size (2023) |
US$7.1 Bn |
|
microfluidic devices market Size (2033) |
US$20.9 Bn |
|
Forecast Growth Rate (CAGR 2024 to 2033) |
10.2% |
|
Historical Growth Rate (CAGR 2019 to 2023) |
14% |
Report Sample is Available
In-depth report coverage is now just a few seconds away
Get Report Sample
Microfluidic devices utilize the physical and chemical characteristics of liquids and gases on a small scale. Microfluidic devices provide numerous advantages compared to systems of conventional size.
Microfluidics enables the examination and utilization of smaller quantities of samples, chemicals, and reagents, hence reducing the overall costs of applications.
Microfluidic systems are extensively utilized in several operations, including capillary electrophoresis, isoelectric focusing, immunoassays, flow cytometry, sample injection in mass spectrometry, PCR amplification, DNA analysis, separation and manipulation of cells, and cell patterning.
Several key manufacturers in the microfluidic devices market are utilizing 3D printing technology in the manufacturing process of microfluidic devices.
The growing usage of 3D printing technology is because 3D printing facilitates the overall production of microfluidic devices in a single process.
Furthermore, the 3D printing technology enables the rapid modification of device features with each of its prints through modification of the design in CAD software.
With the increased usage of 3D printing technology, there have been significant growth opportunities anticipated for the microfluidic device industry owing to the increasing demand for point-of-care diagnostics.
Instead of other conventional methods, these diagnostics offer a rapid and reliable method of disease detection, which allows healthcare professionals to make rapid medical decisions about the patient and improves the diagnosis.
Prospects for microfluidics device-based applications in point-of-care testing are also being generated by the miniaturization of microfluidic devices and the production of novel products.
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized VersionThe global microfluidic devices market saw an impeccable growth during the historical period from 2019 to 2022, where the market saw a staggering growth rate of 14%.
The market has experienced substantial growth in recent years, which is primarily fuelled by the widespread adoption of microfluidic devices and the extensive research and development activities that have been conducted.
Microfluidic systems are essential for rapid and precise testing, as the demand for point-of-care diagnostics has been heightened by the geriatric population, which is susceptible to a variety of diseases.
Furthermore, government funding for genomics and proteomics research has driven the market forward, necessitating the development of technologies that are efficient, time-saving, and low-fluid, such as microfluidics.
In response to this, several key manufacturers in the market have developed microfluidic flow cells and devices to facilitate high-throughput genomic and proteomics research, thereby influencing the changing healthcare landscape.
The healthcare industry's ongoing evolution primarily is anticipated to propel the market to maintain its growth trajectory, fuelled by the demand for innovative technologies that facilitate effective diagnostics.
Furthermore, throughout the forecast period, the said market is expected to capitalize on the rapid adoption and growing acceptance of new technologies, particularly in emerging economies.
Widening Application of microfluidics
Microfluidic technology allows for exact volume manipulation of samples outside of cellular environments. As a result, it will eventually be conceivable to diminish disparities between in-vivo and in-vitro settings and drastically cut on both the time required for reaction rates and overall cost.
To better comprehend in vivo conditions, microfluidic techniques have made significant advancements, which includes Micro-arrays and cell-based microarrays.
Both, when combined with other cutting-edge technologies like optical and electrical detection techniques and a well-designed microfluidic system, have been proven beneficial for tracking changes in cellular behavior due to environmental influences.
Additionally, the cell-based micro-arrays can aid in the correct adhesion or development of numerous cell types on various substrates.
The development of innovative arrays has so far involved several concepts, including suspension arrays, also known as high-throughput cell-based assays, and positional arrays, also known as multiplexed cell-based arrays.
Furthermore, state-of-the-art innovations, including lab-on-a-chip and organs-on-a-chip, are being made to advance the state-of-the-art microfluidic technologies. The projects for organs-on-a-chip and labs-on-a-chip are anticipated to continue being the focus of intensive research in a variety of fields of research and material-based sectors.
Application of Cost-effective Materials
The emphasis on the utilization of cost-effective materials for the production of microfluidic circuits and sensors is a crucial factor driving the global microfluidic devices market.
The precise passage of microfluids is essential for the effective diagnosis of the disease, drug delivery, or cellular analysis. For this reason, the manufacturing of chips and sensors necessitates the use of high-quality materials and components.
Key manufacturers of the market are currently emphasizing the use of cost-effective materials, such as polymers and paper, in the development of processors and sensors, as glass is an expensive material.
Paper is a valuable substrate for applications that necessitate the manufacturing of circuits and sensors that are user-friendly, robust, disposable, and flexible.
Additionally, the market has encountered apparent constraints due to the high cost of reagents and materials. The primary objective of each microfluidic device manufacturing company is thus to eliminate these obstacles.
High Material Costs
The high development costs of microfluidic devices market chips and devices come with risks and limitations that could impede the growth of the global market.
With the extension of microfluidic applications, the limitations of the conventional monolithic microfluidic chips are becoming increasingly apparent.
One of the major restraining factors for the market is the high costs associated with the research & development of the products based on microfluidic technology and the lack of financial assistance.
Furthermore, the lengthy development periods for R&D projects coupled with the high costs of the clinical trials required to assess the devices and chips add to the significant expense it incurs.
Additionally, silicon and glass are used in the fabrication of microfluidics systems, which is performed in a clean room. Due to its transparency to visible and ultraviolet light, silicon is a material that cannot be used with microscopic technologies.
Both glass and silicon have challenging bonding procedures for closing micro channels, making them both brittle materials. Additionally, they call for labor-intensive and expensive fabrication techniques, which are anticipated to restrain market expansion throughout the forecast period.
New Product developments
The global microfluidic devices market is expected to offer various opportunities during the forecast period.
Considering the rapid advancements in technology and increasing demand for point-of-care testing and personalized medicine, there is a growing need for innovative microfluidic devices across various industries.
The key opportunities in the global market include the development of advanced point-of-care diagnostic devices, increased adoption of microfluidic technology in drug discovery and development, and the growing application of microfluidic devices in genomics research and analysis.
Additionally, the integration of microfluidic devices with artificial intelligence and the Internet of Things (IoT) presents opportunities for enhanced data analysis and real-time monitoring in healthcare and life sciences.
With this, the global microfluidic devices market is expected to have significant growth during the study period and create new avenues for innovation and collaboration in the industry.
Microfluidic Chips Responsible for 85% Market Share by Value
|
Market Segment by Device Type |
Market Value Share |
|
Chip |
85% |
Based on the device type segmentation, the microfluidic devices market is further segmented into chips, and sensors, where the chip segment has a major market share.
The reason for the dominance of chip segmentation is its high potential to be used in several applications, like life science, drug delivery, diagnostics and biomedical.
Furthermore, it is estimated to dominate the global market share with the highest CAGR during the said forecast period owing to its quick reaction time, cost-effectiveness, improved sensitivity and ease of integration in several devices.
The sensors segment is also said to have a steady growth rate owing to its capacity to detect a small volume in a timely manner, as well as their ability to reduce reagent and energy consumption, waste, and cost, are all factors that contribute to the growth of the sensors segment.
It is anticipated that these factors will contribute to the expansion ofmarket during the forecast period.
Glass Remains the Most Sought-After Materials Category
|
Market Segment by Material |
Market Value Share |
|
Glass |
35% |
Based on the material type segmentation, the market is further segmented into glass and polymer, where the glass segment dominates the market share.
The glass segment dominates other types of materials owing to its good chemical, electrical and physical properties that are required for an accurate flow of micro fluids for detection of diseases.
As glass provides higher accuracy and sensitivity than any other material, it is mostly utilized in such important applications, which is eventually aiding the growth of the microfluidic systems market.
North American region dominates the global market with a major market share and a growth rate of almost 20% during the forecast period.
The region is expected to maintain its position as the largest stakeholder in the market owing to the presence of major healthcare and technology giants operating from the region.
The North American market is expanding due to the firms and government organizations sponsoring research at a higher rate.
Furthermore, the need for microfluidics devices in the diagnostics and research domains to expedite the commercialization of lab-built devices has propelled the industry-academia collaboration.
For example, in July 2020, Fluidigm Corporation signed a letter of cooperation for the Rapid Acceleration of Diagnostics program with the National Institutes of Health and the National Institute of Biomedical Imaging and Bioengineering.
The project, which had a maximum budget of US$37 million, sought to use Fluidigm's microfluidics technology to boost the production and output capacities of COVID-19 testing.
In addition, the program expedited the development and commercialization of innovative technologies to significantly increase the capacity for SARS-CoV-2 testing in the US.
Asia Pacific Awaits Elevated Prospects
On the other hand, Asia Pacific also accounts for a considerable market share. During the forecast period, the region is expected to demonstrate a CAGR of 18.08%, which can be attributed to its well-established scientific infrastructure, growing economy, and cost-effective labor.
Investors from around the world have taken notice of the unexplored microfluidics market in the Asia Pacific region, where the market for microfluidic diagnostic testing was mostly dominated by foreign competitors.
Nevertheless, the primary competitors in the industry are launching captivating and unique items that are both thrilling and engaging in terms of performance and, most crucially, attractive in terms of pricing.
Furthermore, the Chinese government has implemented a strategic plan to significantly enlarge the home market and position the country as a prominent participant.
The "Made in China 2025" strategy places particular emphasis on the development and production of pharmaceuticals and medical products.
The strategic implementation of microfluidic technology is expected to yield a favorable return on investment due to its crucial role in life sciences and diagnostics applications.
November 2022 -
In November 2022, Horizon Micro Technologies, launched its template-based 3D microfabrication technology, which aids in manufacturing of conductive micro additive with micro-meter scale accuracy.
January 2023 -
In January 2023, SCIEX launched its Intabio ZT system, which is a fully-integrated microfluidic chip-based platform.
November 2022 -
In November 2022, LumiraDX introduced its new product called Rapid Microfluidic Immunoassay C-Reactive Protein Test to test the antimicrobial resistance in India.
The major competitors in the microfluidic devices market are primarily evaluated based on their product or service offerings, their financial statements, developments and the approaches implemented, the company's position in the global market scenario and its geographical reach.
Apart from this, the key competitors studied have also been accessed through the SWOT analysis to understand their strengths, weaknesses, opportunities and threats.
The key competitors in the industry employ crucial strategies like partnership deals, mergers and acquisitions, and business expansion deals to strengthen their hold on a particular region or a particular service offering.
|
Attributes |
Details |
|
Forecast Period |
2024 - 2033 |
|
Historical Data Available for |
2019 - 2022 |
|
Market Analysis |
US$ Billion for Value |
|
Key Countries Covered |
|
|
Key Companies Profiled |
|
|
Pricing |
Available upon request |
By Device Type
By Material
By Region
For report customisation and delivery information contact our sales representative.
The global market is currently valued at around US$ 6.9 Bn in 2022.
Sales of the market are set to witness growth at a CAGR of 10.2% and be valued at around US$ 20.9 Bn by 2033.
Demand for the global market increased at a 14.0% CAGR from 2014 to 2022.
The U.S., Japan, Canada, China, and Russia account for most demand within the market, currently holding around 46.8% market share.
The U.S. accounts for around 64.0% share of the North American market in 2022.
Latin America accounts for around 9.3% share of the global market in 2022.
China held a market share of about 5.5% of the global market in 2022
U.K. held around 3.7% market share of the global market in 2022.
The Brazil market is expected to grow at an 8.8% CAGR during the forecast period.
The market in India is set to expand at an 11.6% CAGR over the forecast period.
